Windtree Therapeutics (WINT) Stock Price
Windtree Therapeutics Price
Over the last 14 years Windtree Therapeutics grew revenue by 2.8% annually, reaching 198,000.00 USD. For Windtree Therapeutics, the net margin of -13,876.3% is down versus -5,589.7% a few years ago.
Windtree Therapeutics stock price
Windtree Therapeutics business model & stock analysis
Frequently asked questions about Windtree Therapeutics
6 analysts currently rate the Windtree Therapeutics stock: 0 recommend buying, 3 holding and 3 selling. For 2026, analysts expect Windtree Therapeutics to generate revenue of 12.40 M USD and earnings per share of -165.94 USD.
Converted at the current exchange rate, the Windtree Therapeutics share trades at 0.00 EUR (0.00 USD).
The Windtree Therapeutics share (WINT) is listed on 1 stock exchanges, including: NASDAQ (WINT).
The expected revenue of Windtree Therapeutics is 12.40 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Windtree Therapeutics is -42.55 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Windtree Therapeutics is currently -0.00. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Windtree Therapeutics stock.
The price-to-sales ratio (P/S) of Windtree Therapeutics is currently 0.00. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Windtree Therapeutics stock.
The Eulerpool Quality Score for Windtree Therapeutics is 2/10.
The ISIN of Windtree Therapeutics is US97382D6004. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Windtree Therapeutics is A2P3ZQ. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Windtree Therapeutics is WINT. The ticker symbol is used to trade Windtree Therapeutics shares on the stock exchange.
Windtree Therapeutics stock
Windtree Therapeutics Peer Group
Windtree Therapeutics Ticker
All fundamentals and in-depth analysis of Windtree Therapeutics
Our stock analysis for Windtree Therapeutics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Windtree Therapeutics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.